Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Breast Carcinoma

Clinical trial condition

Recurrent Breast Carcinoma

Explore clinical trials studying Recurrent Breast Carcinoma. Study availability and eligibility vary by location and protocol.

71 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Breast Carcinoma trial results

Completed

Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer

NCT02415387

Conditions: Behavior, Behavioral Symptoms, Breast Diseases, +13 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Wexner Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer

NCT02996825

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +25 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope Upland Upland, California, United States

View Trial Details

Completed

Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer

NCT02672475

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +10 more
Locations: Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer

NCT01622868

Conditions: Brain Diseases, Brain Neoplasms, Breast Diseases, +14 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

The Kirklin Clinic at Acton Road Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States

View all 302 locations

View Trial Details

Completed

Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer

NCT04022772

Conditions: Adenocarcinoma, Breast Carcinoma, Breast Carcinoma In Situ, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer

NCT02898207

Conditions: Breast Diseases, Breast Neoplasms, Metastatic High Grade Fallopian Tube Serous Adenocarcinoma, +27 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy

NCT01922921

Conditions: Breast Diseases, Breast Neoplasms, HER2/Neu Positive, +6 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice

NCT04297384

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Breast Diseases, +8 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer

NCT03364348

Conditions: Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +10 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States

View Trial Details

Completed

MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer

NCT02536794

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +8 more
Locations: Northwestern University Chicago, Illinois, United States

Northwestern University- Lake Forest Hospital Lake Forest, Illinois, United States

View Trial Details